about
C-reactive protein, pentraxin-relatedAPOBApolipoprotein BHeparan sulfate proteoglycan 2LDL receptor related protein associated protein 1LanC like 1Adaptor related protein complex 2 subunit mu 1Ankyrin repeat family A member 2Sorting nexin 17Clathrin heavy chainDickkopf WNT signaling pathway inhibitor 1Adaptor related protein complex 2 subunit alpha 1Mesoderm development LRP chaperonePhosphatidylinositol binding clathrin assembly proteinProprotein convertase subtilisin/kexin type 9DnaJ heat shock protein family (Hsp40) member A1Heat shock protein 90 beta family member 1Synaptotagmin 1Apolipoprotein A5Apolipoprotein EClusterinLanC (bacterial lantibiotic synthetase component C)-like 1Clathrin, heavy polypeptide (Hc)DnaJ heat shock protein family (Hsp40) member A1Mesoderm development LRP chaperoneCOMM domain containing 1Low density lipoprotein receptor adaptor protein 1Ankyrin repeat, family A (RFXANK-like), 2SacsinLow density lipoprotein receptor-related protein associated protein 1Apolipoprotein A-VLow density lipoprotein receptor-related protein 2Adaptor-related protein complex 2, alpha 1 subunitAdaptor-related protein complex 2, mu 1 subunitHeat shock protein 90, beta (Grp94), member 1Dickkopf WNT signaling pathway inhibitor 1Low-density lipoprotein receptor-related protein 1BMatrix metallopeptidase 13Proprotein convertase subtilisin/kexin type 9Sorting nexin 17
P680
Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand bindingBinding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradationThe PX-domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptorApoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complexARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic miceAssociation between a specific apolipoprotein B mutation and familial defective apolipoprotein B-10039 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related proteinSequence-specific recognition of a PxLPxI/L motif by an ankyrin repeat tumbler lockDominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3----Lys) and its binding to low density lipoprotein receptors.
P921
Q14859863-1E15D81E-E759-47BC-AEC3-15C6EDF459B3Q14890615-0485DE1C-BC8A-412E-B31F-51631C18BCAAQ14890657-D9742511-3423-4AEA-AB3E-772CF6B57356Q2071346-79ADE4DD-3F31-4AC4-B5FA-AA0A2C25B71DQ21097389-38E3C1C2-76B6-4AED-A3F0-014D4B031CDAQ21097389-A2C77628-E024-452C-AF27-07AFAEDF1685Q21105893-2FAAEC1F-444F-4504-8526-190631D47C81Q21106418-2B768A82-1565-4E1F-AF29-E8F4339ACBACQ21108204-E7395EF7-AF1E-4677-BF0D-A42F3335EE4EQ21109025-E364A82A-502D-46F7-9D66-A7C20B6922C8Q21109804-49B29E04-F7DE-472D-8AE2-4004C609DFC9Q21112227-8E124D2A-ABED-4CA1-B358-0D245C9A42FCQ21116554-54F8C853-A972-4E6E-9292-AD2FBFED0DDEQ21120829-8E2B91C2-E8E1-4142-B896-E2A97BC7A633Q21120829-F3C77966-0574-45D5-B143-AD3590518086Q21121978-AC6CF3FA-9BE5-4F20-9C6A-AD3DF95828A7Q21130010-DA91C7C5-1927-45E5-93C8-2AAB03990713Q21130854-5828EED5-7B0E-47BE-BE59-5450AE12B0BDQ21131370-9ECF5F07-BC15-4A98-86C9-DA3B9292FEC2Q21171815-13875D36-8E5E-4332-830B-7145CEB337DBQ21173178-88B9F801-8639-4CB9-9C6B-84CE6500194DQ21416505-2A40A8EB-2C65-4867-9390-370FF0E804E8Q21416505-E04CF011-70CD-4653-B913-A56C2BFAC2CFQ21426592-84DCFAE6-24FB-4229-8C78-01BB26E460C0Q21494691-DF89E8F0-7517-4895-A0C1-894911FA1B16Q21495098-B510DB53-F415-4DB4-AA9A-E51A82D2D54EQ21495229-DD105E12-D0B9-4FE0-A81C-EBC0919A411CQ21495927-5F955B86-304A-4885-B682-F64B9F265265Q21495927-A8A617BD-AC75-4DFC-B546-FE272EFF10EFQ21496290-11AAE3B2-5BB6-4CF5-A181-E43CE84518CAQ21496937-47E74E97-4FCB-4E01-AB4F-A92A145EBAC9Q21499001-10C10D28-95BE-4EE2-93E8-2A98BBF73C14Q21980165-38BD707B-BDF8-46F1-BA62-EEC72529ED5BQ21980328-8E9A044D-610E-44EC-924E-49A6C0023493Q21980338-1D806AAE-0E20-4602-A8BF-65B058A1B1D8Q21981311-06177D34-FF30-4D0D-853B-55AB884250B6Q21982736-0865F09C-5939-4862-A451-01ED5AE85981Q21982743-957694BA-23B6-4D69-B11F-B5A40DCDB618Q21982743-D9699B3F-6388-4972-9497-521DF12B5298Q21983247-60C1D30E-59DC-4CCB-9966-938B9E891704
P680
Q24293425-C341EC01-B385-4757-BDD4-90761A55659BQ24303660-F550D8E4-A95A-4B7E-9A78-0C7557F1F139Q24304115-83FAAA11-0CCE-49D4-B7AB-7709C3C922E5Q24304510-94E7FBC3-91A4-4F2A-AF0A-0B02B0CCBA2CQ24306476-2BB69589-5E93-4CF3-83D5-2F53B2134475Q24311328-52A9B4C4-E29A-4D32-B438-A4DE7FE7FFF8Q24316428-8206082A-A77E-4FA2-AE36-3187A8D2531DQ24568257-52A65969-08F7-4F17-9F0C-DC78BE03C0BBQ27679372-3F71E315-8077-4FC6-BD6C-58CD94AE9666Q35753304-4C0782FD-947C-4C58-A20D-568DAD54F4BDQ44773567-84BC7845-A8A6-42CE-A2CB-07383C12BC15
P921
description
Interacting selectively and non-covalently with a low-density lipoprotein receptor.
@en
biologisch proces
@nl
name
low-density lipoprotein particle receptor binding
@en
type
label
low-density lipoprotein particle receptor binding
@en
altLabel
GO:0050750
@en
LDL receptor binding
@en
low-density lipoprotein receptor binding
@en
prefLabel
low-density lipoprotein particle receptor binding
@en
P2888
P686
GO:0050750